Learn about TAKHZYRO (lanadelumab-flyo), a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12+ years. Read about its efficacy, safety and more. See Important Safety Information.
| Website | http://www.takhzyro.com |
| Revenue | $4 million |
| Employees | View employees |
| Industry | Pharmaceuticals, Healthcare |
| Competitors | Shire, Amgen, Biogen, Lilly India, Genentech, AstraZeneca, Novartis, Regeneron, Roche, Merck & Co., Inc. +39 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Dyax Corp employee's phone or email?
Dyax Corp Questions
The Dyax Corp annual revenue was $4 million in 2026.
The NAICS codes for Dyax Corp are [32, 325].
The SIC codes for Dyax Corp are [28, 283].
G2Crowd Trusted
300K+
Plugin Users
